Leukemia, Myelodysplasia, Transplantation
News
FDA approves first biosimilar product
A biosimilar product is approved based on data showing that it is highly similar to an already-approved biological product. Sandoz Inc’s Zarxio...
News
Aggressive infant leukemia has few mutations
Photo by Vera Kratochvil Infants who have acute lymphoblastic leukemia (ALL) with MLL rearrangements have few other mutations, according to new...
Conference Coverage
‘Biodegradable’ CAR may aid transplant in AML
Photo courtesy of BMT Tandem Meetings SAN DIEGO—Researchers have developed a “biodegradable” chimeric antigen receptor (CAR) T-cell therapy that...
News
Studies help explain multidrug resistance in cancer
(right) and Sung Chang Lee Photo courtesy of The Scripps Research Institute Scientists have discovered how the primary protein responsible for...
News
Cancer care spending doesn’t correlate to lives saved
Photo by Rhoda Baer A new analysis suggests that although US spending on cancer treatment has increased greatly in recent years, cancer mortality...
News
Why CLL patients stop taking ibrutinib
Photo courtesy of CDC In reviewing 4 clinical trials of ibrutinib, researchers found that a quarter of chronic lymphocytic leukemia (CLL)...
News
Clonal hematopoiesis is more common than we thought, group says
in the bone marrow The incidence of clonal hematopoiesis in the general population may be higher than we thought and appears to increase...
News
Quick antibiotic delivery reduces intensive care needs
Photo by Logan Tuttle Time is of the essence when delivering antibiotics to pediatric cancer patients who present with fever and neutropenia, a...
News
Skiing accident claims life of leukemia expert
Photo courtesy of RPCI Meir Wetzler, MD, Chief of the Leukemia Section at the Roswell Park Cancer Institute (RPCI) in Buffalo, New York, has died...
News
Variant may predict risk of toxicity in ALL
Kristine Crews, Barthelemy Diouf, and William Evans Photo by Seth Dixon A gene variant may help predict vincristine-related toxicity in children...
News
Treatment likely doesn’t increase risk of cancer
Pimecrolimus, a topical cream used to treat eczema in children, does not appear to confer an increased risk of hematologic and other cancers,...